Trial intelligence / Profile preview

Anesthetic Technique Effects on NK Cells in Abdominal Surgery

NCT02669186Enrolling by invitation

Sponsor
Cedars-Sinai Medical Center
Start
Jul 2019
Primary completion
Dec 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, single-blind trial of fentanyl in pain (2 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Natural Killer Cell Cytotoxicity at 1 year. Started Jul 2019; status: enrolling by invitation.

02

Drugs

fentanyl
03

Conditions

pain

Beyond the preview

Go deeper on NCT02669186.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02669186.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call